Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients

Respir Physiol Neurobiol. 2014 Apr 1:194:54-61. doi: 10.1016/j.resp.2014.01.018. Epub 2014 Feb 1.

Abstract

Lung diffusing capacity for CO (DLCO) is compromised in haematopoietic stem-cell transplantation (HSCT) recipients. We derived alveolar-capillary membrane conductance (DM,CO) and pulmonary capillary volume (VC) from DLCO and diffusing capacity for NO (DLNO). Forty patients were studied before and 6 weeks after HSCT. Before HSCT, DLNO and DLCO were significantly lower than in 30 healthy controls. DM,CO was ∼40% lower in patients than in controls (p<0.001), whereas VC did not differ significantly. After HSCT, DLNO and DM,CO further decreased, the latter by ∼22% from before HSCT (p<0.01) while VC did not change significantly. Lung density, serum CRP and reactive oxygen metabolites were significantly increased, with the latter being correlated (R2=0.71, p<0.001) with the decrement in DLNO. We conclude that DLNO and, to a lesser extent, DLCO are compromised before HSCT mainly due to a DM,CO reduction. A further reduction of DM,CO without VC loss occurs after HSCT, possibly related to development of oedema, or interstitial fibrosis, or both.

Trial registration: ClinicalTrials.gov NCT01735526.

Keywords: Alveolar–capillary membrane conductance; Carbon monoxide; Lung density; Nitric oxide; Pulmonary capillary volume; Reactive oxygen metabolites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Gas Analysis
  • C-Reactive Protein / metabolism
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Lung / diagnostic imaging
  • Lung / physiopathology*
  • Male
  • Middle Aged
  • Pulmonary Diffusing Capacity / physiology*
  • Reactive Oxygen Species / blood
  • Respiratory Function Tests
  • Spirometry
  • Tomography, X-Ray Computed
  • Young Adult

Substances

  • Reactive Oxygen Species
  • C-Reactive Protein

Associated data

  • ClinicalTrials.gov/NCT01735526